# Rafael Simó

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rafael-simo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,430 |
| Field | Retinal Diseases and Treatments |
| h-index | 81 |
| i10-index | 341 |
| Last Known Institution | Universitat Autònoma de Barcelona |
| OpenAlex ID | https://openalex.org/A5091908088 |
| ORCID iD | https://orcid.org/0000-0003-0475-3096 |
| Works | 613 |

## Researcher papers

- [Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial](https://scholariq.org/papers/anti-interleukin-21-antibody-and-liraglutide-for-the-preservation-of-cell/)
- [Study of the Potential Association of Adipose Tissue GLP-1 Receptor with Obesity and Insulin Resistance](https://scholariq.org/papers/study-of-the-potential-association-of-adipose-tissue-glp-1-receptor-with-obesity/)

## Researcher topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Retinal Imaging and Analysis](https://scholariq.org/topics/retinal-imaging-and-analysis/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Advanced Glycation End Products research](https://scholariq.org/topics/advanced-glycation-end-products-research/)

## Researcher university

- [Universitat Autònoma de Barcelona](https://scholariq.org/institutions/universitat-autonoma-de-barcelona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.